"Immunity, Mucosal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nonsusceptibility to the pathogenic effects of foreign microorganisms or antigenic substances as a result of antibody secretions of the mucous membranes. Mucosal epithelia in the gastrointestinal, respiratory, and reproductive tracts produce a form of IgA (IMMUNOGLOBULIN A, SECRETORY) that serves to protect these ports of entry into the body.
| Descriptor ID |
D018928
|
| MeSH Number(s) |
G12.450.573
|
| Concept/Terms |
Immune Response, Mucosal- Immune Response, Mucosal
- Immune Responses, Mucosal
- Mucosal Immune Response
- Mucosal Immune Responses
|
Below are MeSH descriptors whose meaning is more general than "Immunity, Mucosal".
Below are MeSH descriptors whose meaning is more specific than "Immunity, Mucosal".
This graph shows the total number of publications written about "Immunity, Mucosal" by people in this website by year, and whether "Immunity, Mucosal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 1 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 2 | 3 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 3 | 4 |
| 2017 | 11 | 12 | 23 |
| 2018 | 4 | 10 | 14 |
| 2019 | 3 | 4 | 7 |
| 2020 | 0 | 3 | 3 |
| 2021 | 4 | 3 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunity, Mucosal" by people in Profiles.
-
Inhibition of elastase enhances the adjuvanticity of alum and promotes anti-SARS-CoV-2 systemic and mucosal immunity. Proc Natl Acad Sci U S A. 2021 08 24; 118(34).
-
Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells. Mucosal Immunol. 2021 11; 14(6):1381-1392.
-
Audio Interview: Aspects of Covid-19 Immunity. N Engl J Med. 2021 08 19; 385(8):e31.
-
Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection. mBio. 2021 08 31; 12(4):e0159821.
-
Mucosal immunity to SARS-CoV-2: a clinically relevant key to deciphering natural and vaccine-induced defences. Clin Microbiol Infect. 2021 12; 27(12):1724-1726.
-
Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management. Drug Discov Today. 2021 11; 26(11):2619-2636.
-
Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice. Sci Rep. 2021 07 21; 11(1):14917.
-
CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus. J Virol. 2021 07 12; 95(15):e0053021.
-
Antibody and B cell responses to SARS-CoV-2 infection and vaccination. Cell Host Microbe. 2021 07 14; 29(7):1063-1075.
-
What should define a SARS-CoV-2 "breakthrough" infection? J Clin Invest. 2021 06 15; 131(12).